Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33…
LINKIN PARK ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI
MILLIONS OF FANS FROM ACROSS THE WORLD TUNED IN TO WATCH THE…
From Declaration to Action: Advancing Global Graft Fight under IAACA Steer
HONG KONG, May 31, 2025 /PRNewswire/ -- In May last year, the…
Fall of Mongolian coalition government could lead to severe economic downturn
Mongolia faces a crunch parliamentary vote on Monday which could lead to…
oneworld alliance Strengthens Leadership Team With Three Key Appointments
DELHI, India, May 31, 2025 /PRNewswire/ -- oneworld® alliance today continues to…
University of Phoenix Announces 2025 UOPX Faculty of the Year Award Recipients
Award honors top UOPX faculty nominated by students and faculty colleaguesPHOENIX--(BUSINESS WIRE)--University…
Rays Power Infra Ltd Achieves Record Revenue of 1350 Crore in FY25, Up 29% from Previous Year
NEW DELHI, May 30, 2025 /PRNewswire/ -- Rays Power Infra Limited, a…
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term…
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence…
Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced…